Status:
COMPLETED
Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Diagnosis, Dual (Psychiatry)
Psychiatric Diagnosis
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
The investigators are proposing a study of treatment adherence in co-occurring psychiatric and drug use disorders (COD). The proposed study uses a 3-cell/condition design, within which 75 adult outpat...
Eligibility Criteria
Inclusion
- Currently being treated with any class of psychotropic medication
- Have used illicit drugs or abused prescription drugs within the past year
- Are not adhering completely to their medication
Exclusion
- Current major depressive episode
- Active suicidal/homicidal ideation/intent
- Current manic episode
- Visiting nurse or living in a facility that distributed medications
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00237822
Start Date
September 1 2003
End Date
December 1 2007
Last Update
October 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University Substance Abuse Center
New Haven, Connecticut, United States, 06519